Wolff, Lennard http://orcid.org/0000-0002-2448-122X
Su, Jiahang http://orcid.org/0000-0002-2212-6128
Van Loon, Derek
van Es, Adriaan http://orcid.org/0000-0001-6119-7247
van Doormaal, Pieter Jan http://orcid.org/0000-0002-7398-2864
Majoie, Charles http://orcid.org/0000-0002-7600-9568
van Zwam, Wim http://orcid.org/0000-0003-1631-7056
Dippel, Diederik http://orcid.org/0000-0002-9234-3515
van der Lugt, Aad http://orcid.org/0000-0002-6159-2228
van Walsum, Theo http://orcid.org/0000-0001-8257-7759
,
Funding for this research was provided by:
Hartstichting
Angiocare BV
Medtronic
MEDAC Gmbh
Penumbra Inc.
Stryker
Top Medical/Concentric
Hersenstichting
Ceronovus
Article History
Received: 17 March 2022
Accepted: 16 May 2022
First Online: 24 May 2022
Declarations
:
: The MR CLEAN study protocol was approved by a central medical ethics committee and the research board of each participating center. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
: All patients or their legal representatives provided written informed consent before randomization in this study.
: Patients signed informed consent regarding publishing their data.
: The authors of this manuscript declare relationships with the following companies: Lennard Wolff: none. Jiahang Su: none. Derek van Loon: none. Adriaan C.G.M. van Es: none. Pieter Jan van Doormaal: none. Prof. Charles B.L.M. Majoie: research grants from CVON/Dutch Heart Foundation, European Commission, TWIN foundation, Stryker, Dutch Health Evaluation program, Stryker (all paid to institution), is shareholder of Nico-lab (modest). Wim H. van Zwam: The Maastricht UMC+ received funds for consultations done by WHZ for Cerenovus and Stryker Neurovascular. Prof. Diederik W.J. Dippel: none. Aad van der Lugt: The Erasmus MC received grants for research from Siemens Healthineers, GE Healthcare, and Philips Healthcare. Theo van Walsum: none.